Titre :
|
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. (2002)
|
Auteurs :
|
Christopher-S MURRILL ;
Beth-P BELL ;
Brian-C CASTRUCCI ;
Marta GWINN ;
Catherine SPRUILL ;
Howard WEEKS ;
Hillard-S WEINSTOCK ;
National Center for Hiv. Std. And Tb Prevention. Centers for Disease Control and Prevention Cdc Atlanta. GA. USA
|
Type de document :
|
Article
|
Dans :
|
American journal of public health (vol. 92, n° 3, 2002)
|
Pagination :
|
385-387
|
Langues:
|
Anglais
|
Mots-clés :
|
Homme
;
Epidémiologie
;
Prévalence
;
Hépatite virale B
;
Virose
;
Infection
;
Sida
;
Sérologie
;
Hépatite virale C
;
Age
;
Voie intraveineuse
;
Toxicomanie
;
Etats Unis
;
Amérique
;
Immunopathologie
;
Foie [pathologie]
;
Appareil digestif [pathologie]
;
Amérique du Nord
|
Résumé :
|
[BDSP. Notice produite par INIST-CNRS 63R0x7E2. Diffusion soumise à autorisation]. Objectives. This study measured age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus (HCV) infection among injection drug users (IDUs) admitted to drug treatment programs in 6 US cities. Methods. Remnant sera collected from persons entering treatment with a history of illicit drug injection were tested for antibodies to HIV, hepatitis C (anti-HCV), and hepatitis B core antigen (anti-HBc). Results. Prevalence of anti-HBo and anti-HCV increased with age and reached 80% to 100% among older IDUs in all 6 cities. Although overall age specific HIV prevalence was lower than anti-HCV or anti HBc, this prevalence was greater in the Northeast than in the Midwest and West Conclusions. The need continues for effective primary prevention programs among IDUs specifically tar geting young persons who have recently started to inject drugs.
|